Medication to prevent throat narrowing after esophagus surgery
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial compares two medications, tranilast and steroids, to see which is better at preventing the esophagus from narrowing after a procedure to remove early-stage cancer or precancerous growths. If you are having this procedure, you may be eligible to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 and can speak and understand Mandarin.
- You are scheduled for or have had a type of endoscopic surgery (cESD) to remove early-stage growths from your esophagus.
- You agree to sign a consent form to join the study.
- You are not allergic to tranilast.
- You do not have other serious medical conditions that could affect your safety.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving budesonide (a steroid medicine) after a stretching procedure (endoscopic dilatation) for a narrowing at the site of a repaired congenital esophageal blockage can help keep the esophagus open and improve swallowing in children. It is for children under 12 who have not had prior stretching for this same narrowing and who meet other specific health criteria.
This study tests whether a paclitaxel-coated balloon can keep the esophagus (food pipe) open longer in people with a stubborn benign narrowing. It aims to improve swallowing by reducing how often the narrowing needs repeat stretching.
This trial tests whether giving the immunotherapy drug sintilimab together with standard chemotherapy and a growth factor injection before surgery can help people with a certain type of esophageal cancer (squamous cell carcinoma) that is still removable. The goal is to improve treatment outcomes before the operation.
This trial tests a combination of an immunotherapy drug (sintilimab) and chemotherapy given before and after surgery for esophageal squamous cell carcinoma. The goal is to see if this approach can improve outcomes for patients with resectable tumors in the middle or lower esophagus.
This trial tests whether giving an immunotherapy drug called tislelizumab before surgery helps shrink esophageal cancer and improve outcomes. It is for people newly diagnosed with early-stage squamous cell esophageal cancer that can be removed surgically.
This study tests a new way to replace a narrowed esophagus (the tube that carries food to the stomach) using a specially treated donor esophagus. It is for people whose esophageal narrowing (stricture) has not improved with standard dilation treatments. The goal is to see if this graft can safely and effectively improve swallowing.
Hear when a new Esophageal Stricture trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.